The North America asparaginase market is expected to grow from US$ 267.71 million in 2022 to US$ 660.94 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028.
The pharmaceutical & food industries across North America have developed at a significant rate and witnessed various developments to maintain the high quality of food and pharmaceutical products. Nowadays, manufacturers are focusing on the nutritional quantity of food. Asparaginase is the main amino acid responsible for the reduction of sugar in fried and baked foods, which are condensed with carbonyl sources. As a result, the consumption of such fried and baked foods has substantially increased across the region. Moreover, the rising application of asparaginase is boosting the demand for food products and pharmaceuticals, which is driving the North America asparaginase market .
The pharmaceutical & food industries across North America have developed at a significant rate and witnessed various developments to maintain the high quality of food and pharmaceutical products. Nowadays, manufacturers are focusing on the nutritional quantity of food. Asparaginase is the main amino acid responsible for the reduction of sugar in fried and baked foods, which are condensed with carbonyl sources. As a result, the consumption of such fried and baked foods has substantially increased across the region. Moreover, the rising application of asparaginase is boosting the demand for food products and pharmaceuticals, which is driving the North America asparaginase market .
Market Overview
The North America asparaginase market is segmented into the US, Canada, and Mexico. The market growth is mainly attributed to the rising prevalence of leukemia and lymphoma in the region. Further, the US accounts for the largest share of the asparaginase market. According to Leukemia & Lymphoma Society, in 2021, 186,400 people in the US were diagnosed with lymphoma, leukemia, and myeloma. Lymphoma and leukemia are common among children and the adolescent population. The high prevalence rate among a large population has created a demand for effective treatment, which has increased the use of asparaginase. As a result, the survival rates for leukemia and lymphoma have increased in the country. Thus, the rising need for treatment options for leukemia and lymphoma has created the demand for asparaginase, which is driving the market growth in the country.North America Asparaginase Market Segmentation
The North America asparaginase market is segmented on the basis of type, application, end-use industry, and country.- Based on type, the North America asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022.
- Based on application, the North America asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further segmented into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others.
- Based on end-use industry, the North America asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held a larger market share in 2022.
- Based on country, the North America asparaginase market is categorized into the US, Canada, and Mexico. Further, the US dominated the market in 2022. Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the North America asparaginase market.
Table of Contents
1. Introduction
3. Research Methodology
4. North America Asparaginase Market - Market Landscape
5. North America Asparaginase Market - Key Market Dynamics
6. Asparaginase Market- North America Analysis
7. North America Asparaginase Market Analysis - By Type
8. North America Asparaginase Market Analysis - By Application
9. North America Asparaginase Market Analysis - By End-use Industry
10. North America Asparaginase Market - Country Analysis
11. Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biovendor, Llc
- Changzhou Qianhong Biopharma Co Ltd
- Creative Enzymes
- Jazz Pharmaceuticals, Inc.
- Medac Gmbh
- Servier Pharmaceuticals Llc
- Taj Pharmaceuticals Limited
- United Biotech (P) Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 97 |
| Published | November 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( $ | $ 267.71 Million |
| Forecasted Market Value ( $ | $ 660.94 Million |
| Compound Annual Growth Rate | 16.3% |
| Regions Covered | North America |
